Frontier Capital Management Co. LLC Lowers Holdings in Veeva Systems Inc. $VEEV

Frontier Capital Management Co. LLC lowered its holdings in Veeva Systems Inc. (NYSE:VEEV) by 12.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 237,739 shares of the technology company’s stock after selling 33,385 shares during the period. Frontier Capital Management Co. LLC owned approximately 0.15% of Veeva Systems worth $68,464,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in VEEV. Vanguard Group Inc. boosted its position in Veeva Systems by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 14,971,425 shares of the technology company’s stock valued at $4,311,471,000 after buying an additional 210,859 shares during the period. Alliancebernstein L.P. raised its stake in shares of Veeva Systems by 10.7% in the first quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock valued at $1,273,884,000 after acquiring an additional 532,269 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Veeva Systems by 0.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 5,203,867 shares of the technology company’s stock valued at $1,205,372,000 after acquiring an additional 34,169 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Veeva Systems by 20.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock valued at $924,754,000 after purchasing an additional 689,700 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in Veeva Systems by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 3,316,274 shares of the technology company’s stock worth $955,030,000 after purchasing an additional 85,516 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 720 shares of Veeva Systems stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $298.12, for a total transaction of $214,646.40. Following the transaction, the senior vice president owned 7,868 shares of the company’s stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Thomas D. Schwenger sold 3,350 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the sale, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 24,665 shares of company stock worth $7,438,000. Corporate insiders own 10.30% of the company’s stock.

Wall Street Analysts Forecast Growth

VEEV has been the topic of a number of analyst reports. BTIG Research reaffirmed a “buy” rating and issued a $340.00 price target on shares of Veeva Systems in a research report on Friday, November 21st. Piper Sandler upped their target price on shares of Veeva Systems from $325.00 to $355.00 and gave the stock an “overweight” rating in a research note on Thursday, August 28th. Needham & Company LLC reiterated a “buy” rating and issued a $355.00 price target on shares of Veeva Systems in a research note on Friday, November 21st. TD Cowen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating and boosted their price target for the stock from $297.00 to $380.00 in a report on Tuesday, October 7th. Finally, Canaccord Genuity Group restated a “buy” rating on shares of Veeva Systems in a report on Tuesday, November 25th. Nineteen research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Trading Down 1.2%

VEEV stock opened at $229.32 on Thursday. The company’s 50 day moving average is $276.34 and its two-hundred day moving average is $278.83. Veeva Systems Inc. has a twelve month low of $201.54 and a twelve month high of $310.50. The stock has a market cap of $37.70 billion, a P/E ratio of 44.62, a PEG ratio of 1.72 and a beta of 1.05.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, topping the consensus estimate of $1.95 by $0.09. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. The firm had revenue of $0.81 million for the quarter, compared to analyst estimates of $792.37 million. During the same period last year, the business earned $1.75 EPS. Veeva Systems’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, equities research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.